Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer

被引:128
作者
Leung, WK
Kim, JJ
Kim, JG
Graham, DY
Sepulveda, AR
机构
[1] Vet Affairs Med Ctr, Digest Dis Sect 111D, Dept Med, Houston, TX 77030 USA
[2] Vet Affairs Med Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Korea Univ, Coll Med, Guro Hosp, Seoul 136701, South Korea
关键词
D O I
10.1016/S0002-9440(10)64758-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The role and significance of microsatellite instability (MSI) in gastric carcinogenesis remain unknown. This study determined the chronology of MSI in gastric carcinogenesis by examining intestinal metaplasia (IM) from patients with and without gastric can cer. DNA was obtained from gastric specimens of 75 patients with gastric LM (30 cancer, 26 peptic ulcer, and 19 chronic gastritis patients) and was amplified with a set of eight microsatellite markers. Eight (26.7%) tumors and seven (9.3%) IM samples (three from cancer-free patients) displayed high-level MSI (three or more loci altered). Low-level MSI (one or two loci altered) was detected in 50% of the tumors, in 40% of IM samples coexisting with cancer, and in 38% of IM tissues of cancer-free individuals. Among the 30 cancer patients, microsatellites were more frequently altered in LM coexisting with tumors that showed MSI (P = 0.003). In addition, patients with low-level MSI in the tumor tissues were more likely to have active Helicobacter pylori infection than those with stable tumors (P = 0.02). In conclusion, this study indicates that MSI occurs not only in gastric IM of patients with gastric carcinoma, but also in IM of cancer-free individuals. These data suggest that the progressive accumulation of MSI in areas of IM may contribute to gastric cancer development, representing an important molecular event in the multistep gastric carcinogenesis cascade.
引用
收藏
页码:537 / 543
页数:7
相关论文
共 42 条
[1]   CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]  
Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO
[3]  
2-J
[4]  
Boland CR, 1998, CANCER RES, V58, P5248
[5]  
Brentnall TA, 1996, CANCER RES, V56, P1237
[6]  
BRITO MJ, 1994, EUROPEAN JOURNAL OF CANCER PREVENTION, VOL 3, SUPPLEMENT 2, DEC 1994, P47, DOI 10.1097/00008469-199412002-00008
[7]  
Chang CL, 1999, GASTROENTEROLOGY, V116, pA386
[8]  
CORREA P, 1995, AM J SURG PATHOL, V19, pS37
[9]  
CORREA P, 1988, CANCER RES, V48, P3554
[10]  
CORREA P, 1994, CANCER RES, V54, pS1941